Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9530)	6/11/1998 7:13:00 PM
From: DaiS	Read Replies (1) \| Respond to of 23519

Vlad, That is good. Here it is not a problem as on NHS muse will be so cheap for most patients. Can I ask you a few questions that still I have not got any kind of answers. 1. The Q of muse + SEPA/DMSO to improve drug uptake. I cannot understand why not already in muse pellet. How is it possible that we do not know whether they are working on this. 2. This silly question of why sildenafil cannot be applied intraurethrally as it acts locally. Is it that the drug would not be taken up. Do you know?? 3. The muse burning, why not topical anaesthetic? Surely some urologist must have experimented on himself with this? DaiS

To: VLAD who wrote (9530)	6/11/1998 7:24:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

just a little more positive news: A technical perspective on Vivus stock price: Volume is drying out. Very little price movement over last 3 days. Last 2 days have been very bad for NASDAQ stocks in general--Vivus stock remaining stable. Little volume and little price movement usually an indication for a trend reversal. I think Vivus will move on news only and not on general market conditions. Bearing no news I think Friday will be a repeat of the last 2 days. Mondays script data will tell us where we are heading from here. Plant approval should also lend some price support. Vivus needs to release frequent informative news releases regarding anything involving it's international deals/markets. England has liked MUSE but I have seen no press releases as of yet. I would like to know when some of the other approved countries will eventually sell MUSE. This game is all about companies making money. As soon as that new plant is running at full capacity and Vivus is supplying those other countries we will see some good earnings income. A lot of money is leaving the tech sector (SOX index hit 52 week low today). Fundies will now be looking for other sectors to rotate money into. Hopefully they will notice the fundamentals of this "sleeper".